Researchers are excited about the medication , a novel dual treatment showing remarkable results in early trials for weight loss . It acts by targeting two hormones : GLP-1 and GIP, which , when engaged , https://kianawrmb777493.gynoblog.com/39586952/the-new-possibility-for-weight-management